Chevalier M, Allain V, Gras J, Racle J, Villemonteix J, Divard G
Sci Adv. 2025; 11(10):eadt3499.
PMID: 40043107
PMC: 11881896.
DOI: 10.1126/sciadv.adt3499.
Chiang H, Liang C, Hsiao Y, Le U, Chang Y, Chen P
Kidney Med. 2025; 7(3):100959.
PMID: 39990101
PMC: 11847305.
DOI: 10.1016/j.xkme.2024.100959.
Nuno M, Pugh S, Ji L, Piao J, Dignam J, Steingrimsson J
J Natl Cancer Inst Monogr. 2025; 2025(68):30-34.
PMID: 39989040
PMC: 11848027.
DOI: 10.1093/jncimonographs/lgae046.
Takeuchi M, Shinozaki T, Kawakami K
JAMA Netw Open. 2024; 7(12):e2451813.
PMID: 39705032
PMC: 11662250.
DOI: 10.1001/jamanetworkopen.2024.51813.
Loureiro Harrison L, Fu E, Thomson P, Traynor J, Mark P, Stoumpos S
Clin Kidney J. 2024; 17(12):sfae345.
PMID: 39687920
PMC: 11647593.
DOI: 10.1093/ckj/sfae345.
Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective cohort study.
Kongmalai T, Tansawet A, Pattanaprateep O, Ratanatharathorn C, Amornritvanich P, Looareesuwan P
BMJ Open. 2024; 14(12):e090226.
PMID: 39672582
PMC: 11647382.
DOI: 10.1136/bmjopen-2024-090226.
Clinical trial emulation in nephrology.
Zoccali C, Tripepi G
J Nephrol. 2024; 38(1):11-23.
PMID: 39602027
DOI: 10.1007/s40620-024-02158-5.
Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
Barghout S, Meti N, Chotai S, Kim C, Patel D, Brown M
Br J Cancer. 2024; 132(2):139-153.
PMID: 39572762
PMC: 11746990.
DOI: 10.1038/s41416-024-02899-x.
Review of the target trial methodological approach on treatment effect estimates in kidney failure: protocol for a systematic assessment.
Pinter J, Tunnicliffe D, Karunikaikumar P, Anastasiadis A, Hills R
Syst Rev. 2024; 13(1):280.
PMID: 39543770
PMC: 11566441.
DOI: 10.1186/s13643-024-02672-4.
Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes.
Chen J, Lee C, Yen C, Fan P, Chan M, Tsai T
Kidney Int Rep. 2024; 9(11):3290-3300.
PMID: 39534209
PMC: 11551097.
DOI: 10.1016/j.ekir.2024.08.027.
Conducting observational analyses with the target trial emulation approach: a methodological systematic review.
Simon-Tillaux N, Martin G, Hajage D, Scheifer C, Beydon M, Dechartres A
BMJ Open. 2024; 14(11):e086595.
PMID: 39532374
PMC: 11574403.
DOI: 10.1136/bmjopen-2024-086595.
Psoriasis Risk With Immune Checkpoint Inhibitors.
To S, Lee C, Chen Y, Hsu C, Yang H, Jiang Y
JAMA Dermatol. 2024; 161(1):31-38.
PMID: 39504056
PMC: 11541743.
DOI: 10.1001/jamadermatol.2024.4129.
Target Trial Emulation for Evaluating Health Policy.
Seewald N, McGinty E, Stuart E
Ann Intern Med. 2024; 177(11):1530-1538.
PMID: 39374529
PMC: 11817613.
DOI: 10.7326/M23-2440.
An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury.
Fernandez-Llaneza D, Vos R, Lieverse J, Gosselt H, Kane-Gill S, van Gelder T
Drug Saf. 2024; 48(1):43-58.
PMID: 39327387
PMC: 11711143.
DOI: 10.1007/s40264-024-01474-w.
Myeloproliferative Neoplasms and Dementia Risk: A Population-Based Cohort Study.
Sun Y, Veres K, Hasselbalch H, Frederiksen H, Ostgard L, Horvath-Puho E
Eur J Haematol. 2024; 114(1):45-56.
PMID: 39279726
PMC: 11613695.
DOI: 10.1111/ejh.14297.
An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol.
Mbizvo G, Martin G, Sperrin M, Bonnett L, Schofield P, Buchan I
PLoS One. 2024; 19(8):e0306226.
PMID: 39208329
PMC: 11361671.
DOI: 10.1371/journal.pone.0306226.
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework.
Lambourg E
Nat Rev Nephrol. 2024; 20(12):769.
PMID: 39138342
DOI: 10.1038/s41581-024-00884-4.
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice.
Janse R, Stel V, Jager K, Tripepi G, Zoccali C, Dekker F
Nephrol Dial Transplant. 2024; 40(1):27-33.
PMID: 39020254
PMC: 11852334.
DOI: 10.1093/ndt/gfae170.
Stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical early-stage non-small-cell lung cancer: a population-based study.
Chen H, Cheng W, Tu C, Hsia T, Lin Y, Fang H
Thorac Cancer. 2024; 15(24):1779-1791.
PMID: 39013588
PMC: 11333301.
DOI: 10.1111/1759-7714.15404.
Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome.
Obergfell T, Nydegger K, Heesen P, Schelling G, Bode-Lesniewska B, Studer G
Cancers (Basel). 2024; 16(13).
PMID: 39001505
PMC: 11240342.
DOI: 10.3390/cancers16132443.